Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase Two”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06423326
What this trial is testing

Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic Ductal AdenocarcinomaResectable Pancreatic AdenocarcinomaStage I Pancreatic Cancer AJCC v8+2 more
Emory University 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT04274426
What this trial is testing

Mirvetuximab Soravtansine (IMGN853), in Folate Receptor Alpha (FRα) High Recurrent Ovarian Cancer

Who this might be right for
Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma
AGO Research GmbH 136
Testing effectiveness (Phase 2)WithdrawnNCT01925378
What this trial is testing

A Phase II Single-arm Intervention Trial of Nelfinavir in Patients With Grade 2/3 or 3 Cervical Intraepithelial Neoplasia

Who this might be right for
Cervical Dysplasia
The University of Texas Health Science Center, Houston
Testing effectiveness (Phase 2)Study completedNCT02280785
What this trial is testing

Brentuximab Vedotin for Relapsed/Refractory CD30-positive Non-Hodgkin Lymphomas

Who this might be right for
Non-Hodgkin Lymphoma
Samsung Medical Center 33
Not applicableStudy completedNCT00106678
What this trial is testing

Typology of Adherence in Adolescents: Phase II

Who this might be right for
HIV Infection
University of North Carolina, Chapel Hill 1,200
Large-scale testing (Phase 3)Study completedNCT02818725
What this trial is testing

I-MVAC +/- Panitumumab as First-line Treatment of Advanced Urothelial Carcinoma Without H-Ras Nor K-Ras Mutations

Who this might be right for
Infiltrating Urothelial CarcinomaKRAS Gene Mutation
UNICANCER 133
Testing effectiveness (Phase 2)Study completedNCT01104025
What this trial is testing

Hybrid Immunotherapy for Hemophagocytic LymphoHistiocytosis

Who this might be right for
Hemophagocytic Lymphohistiocytosis
Children's Hospital Medical Center, Cincinnati 31
Testing effectiveness (Phase 2)Enrolling By InvitationNCT05947825
What this trial is testing

Sitagliptin Combined With Gemcitabine and Albumin-bound Paclitaxel in PDAC Patients

Who this might be right for
PDAC - Pancreatic Ductal Adenocarcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT00262925
What this trial is testing

Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
Recurrent Adult Acute Lymphoblastic Leukemia
National Cancer Institute (NCI) 12
Not applicableStudy completedNCT02358876
What this trial is testing

BradyXplore Phase II: Bradykinesia Feature Extraction System

Who this might be right for
Parkinson's Disease
Great Lakes NeuroTechnologies Inc. 32
Not applicableLooking for participantsNCT06886789
What this trial is testing

SMART to Optimize an Intervention to Maintain Health Improvements After Cardiac Rehabilitation

Who this might be right for
Cardiovascular DiseasesCardiac Rehabilitation
The Miriam Hospital 400
Testing effectiveness (Phase 2)Study completedNCT05635968
What this trial is testing

The Clinical Trial of Low Dose Irradiation for Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Kyung Hee University Hospital at Gangdong 71
Testing effectiveness (Phase 2)Study completedNCT00598650
What this trial is testing

A Long-term, Extension Study of E2020 in Patients With Dementia With Lewy Bodies

Who this might be right for
Dementia With Lewy Bodies (DLB)
Eisai Co., Ltd. 160
Testing effectiveness (Phase 2)Study completedNCT02169791
What this trial is testing

Nonmyeloablative Haploidentical Transplant Followed by MLN9708

Who this might be right for
Acute LeukemiaChronic LeukemiaMyelodysplastic Syndrome+2 more
Northside Hospital, Inc. 29
Testing effectiveness (Phase 2)Study completedNCT01432574
What this trial is testing

Study of Gardasil in Mid-Adult Males (MAM)

Who this might be right for
Human Papillomavirus
H. Lee Moffitt Cancer Center and Research Institute 150
Testing effectiveness (Phase 2)Ended earlyNCT01851174
What this trial is testing

Study to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Carcinoma Non-resectableStage IV Pancreatic Cancer
Western Regional Medical Center 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07497074
What this trial is testing

JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 78
Testing effectiveness (Phase 2)Study completedNCT00965718
What this trial is testing

Evaluate the Efficacy and Safety of Activated T-lymphocyte Cell Therapy in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
GC Cell Corporation 20
Testing effectiveness (Phase 2)Study completedNCT04740307
What this trial is testing

Safety and Efficacy of Coformulated Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib (E7080/MK-7902) in Advanced Hepatocellular Carcinoma (MK-1308A-004)

Who this might be right for
Advanced Hepatocellular Carcinoma
Merck Sharp & Dohme LLC 116
Testing effectiveness (Phase 2)Study completedNCT02428192
What this trial is testing

Nivolumab Alone or in Combination With Ipilimumab in Treating Patients With Advanced Uterine Leiomyosarcoma

Who this might be right for
Metastatic LeiomyosarcomaUnresectable LeiomyosarcomaUterine Corpus Leiomyosarcoma
National Cancer Institute (NCI) 20
Next Page